4AB:ETR
AbbVie Common Stock
€ २६५.२०
arrow_downward
-०.३८%(-१.००) 1D
नोभेम्बर १८, ११:१७:०५ GMT+१ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€ २६५.६०
High
€ २६६.४०
Low
€ २६५.२०
Mkt. cap
५.१८ खरब
Avg. vol.
५८१.००
Volume
६०.००
52-wk high
€ २७२.२०
52-wk low
€ १६२.८५
No. of employees
५७ हजार
Open
€ २६५.६०
High
€ २६६.४०
Low
€ २६५.२०
Mkt. cap
५.१८ खरब
Avg. vol.
५८१.००
Volume
६०.००
52-wk high
€ २७२.२०
52-wk low
€ १६२.८५
No. of employees
५७ हजार
News stories
From web sources and news partners
Zacks Investment Research
·
१६ घण्टा पहिले
How Did AbbVie's Neuroscience Franchise Perform in Q3?
Smartkarma
·
४ दिन पहिले
AbbVie Raises 2026 Revenue Guidance to $67.8 Billion: Can Skyrizi and Rinvoq Sustain Growth?
WSJ
·
२ हप्ता पहिले
AbbVie Revenue Rises on Strength in Immunology, Neuroscience
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees५७ हजार
Founded२०१२ अप्रिल १०
HeadquartersNorth Chicago, इलिनोइ, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websiteabbvie.com